157 related articles for article (PubMed ID: 34913532)
1. The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4
Sundararaj S; Seneviratne S; Williams SJ; Enders A; Casarotto MG
Protein Sci; 2022 Apr; 31(4):787-796. PubMed ID: 34913532
[TBL] [Abstract][Full Text] [Related]
2. An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.
Cherian MA; Olson S; Sundaramoorthi H; Cates K; Cheng X; Harding J; Martens A; Challen GA; Tyagi M; Ratner L; Rauch D
J Biol Chem; 2018 May; 293(18):6844-6858. PubMed ID: 29540473
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.
Rauch DA; Olson SL; Harding JC; Sundaramoorthi H; Kim Y; Zhou T; MacLeod AR; Challen G; Ratner L
Retrovirology; 2020 Aug; 17(1):27. PubMed ID: 32859220
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of the IRF4/DNA homodimeric complex.
Sundararaj S; Seneviratne S; Williams SJ; Enders A; Casarotto MG
Nucleic Acids Res; 2021 Feb; 49(4):2255-2265. PubMed ID: 33533913
[TBL] [Abstract][Full Text] [Related]
5. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Nakagawa M; Shaffer AL; Ceribelli M; Zhang M; Wright G; Huang DW; Xiao W; Powell J; Petrus MN; Yang Y; Phelan JD; Kohlhammer H; Dubois SP; Yoo HM; Bachy E; Webster DE; Yang Y; Xu W; Yu X; Zhao H; Bryant BR; Shimono J; Ishio T; Maeda M; Green PL; Waldmann TA; Staudt LM
Cancer Cell; 2018 Aug; 34(2):286-297.e10. PubMed ID: 30057145
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of interferon regulatory factor 4 (IRF4) in a clinical subtype of adult T-cell leukemia.
Imaizumi Y; Kohno T; Yamada Y; Ikeda S; Tanaka Y; Tomonaga M; Matsuyama T
Jpn J Cancer Res; 2001 Dec; 92(12):1284-92. PubMed ID: 11749693
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia/lymphoma cells.
Yasui K; Izumida M; Nakagawa T; Kubo Y; Hayashi H; Ito T; Ikeda H; Matsuyama T
Biochem Biophys Res Commun; 2018 Jul; 501(4):833-837. PubMed ID: 29684346
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for the functional roles of the multimorphic T95R mutation of IRF4 causing human autosomal dominant combined immunodeficiency.
Wang G; Feng X; Ding J
Structure; 2023 Nov; 31(11):1441-1451.e3. PubMed ID: 37683642
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.
Wang L; Toomey NL; Diaz LA; Walker G; Ramos JC; Barber GN; Ning S
J Virol; 2011 Aug; 85(16):8328-37. PubMed ID: 21680528
[TBL] [Abstract][Full Text] [Related]
10. Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.
Wong RWJ; Tan TK; Amanda S; Ngoc PCT; Leong WZ; Tan SH; Asamitsu K; Hibi Y; Ueda R; Okamoto T; Ishida T; Iida S; Sanda T
Blood; 2020 Mar; 135(12):934-947. PubMed ID: 31972002
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional reprogramming by mutated IRF4 in lymphoma.
Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
13. ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent.
Luchtel RA; Zhao Y; Aggarwal RK; Pradhan K; Maqbool SB
Blood Adv; 2022 Oct; 6(20):5613-5624. PubMed ID: 35675522
[TBL] [Abstract][Full Text] [Related]
14. IRF4 mutations in chronic lymphocytic leukemia.
Havelange V; Pekarsky Y; Nakamura T; Palamarchuk A; Alder H; Rassenti L; Kipps T; Croce CM
Blood; 2011 Sep; 118(10):2827-9. PubMed ID: 21791429
[TBL] [Abstract][Full Text] [Related]
15. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
[TBL] [Abstract][Full Text] [Related]
16. A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.
; Fornes O; Jia A; Kuehn HS; Min Q; Pannicke U; Schleussner N; Thouenon R; Yu Z; de Los Angeles Astbury M; Biggs CM; Galicchio M; Garcia-Campos JA; Gismondi S; Gonzalez Villarreal G; Hildebrand KJ; Hönig M; Hou J; Moshous D; Pittaluga S; Qian X; Rozmus J; Schulz AS; Staines-Boone AT; Sun B; Sun J; Uwe S; Venegas-Montoya E; Wang W; Wang X; Ying W; Zhai X; Zhou Q; Akalin A; André I; Barth TFE; Baumann B; Brüstle A; Burgio G; Bustamante JC; Casanova JL; Casarotto MG; Cavazzana M; Chentout L; Cockburn IA; Costanza M; Cui C; Daumke O; Del Bel KL; Eibel H; Feng X; Franke V; Gebhardt JCM; Götz A; Grunwald S; Hoareau B; Hughes TR; Jacobsen EM; Janz M; Jolma A; Lagresle-Peyrou C; Lai N; Li Y; Lin S; Lu HY; Lugo-Reyes SO; Meng X; Möller P; Moreno-Corona N; Niemela JE; Novakovsky G; Perez-Caraballo JJ; Picard C; Poggi L; Puig-Lombardi ME; Randall KL; Reisser A; Schmitt Y; Seneviratne S; Sharma M; Stoddard J; Sundararaj S; Sutton H; Tran LQ; Wang Y; Wasserman WW; Wen Z; Winkler W; Xiong E; Yang AWH; Yu M; Zhang L; Zhang H; Zhao Q; Zhen X; Enders A; Kracker S; Martinez-Barricarte R; Mathas S; Rosenzweig SD; Schwarz K; Turvey SE; Wang JY
Sci Immunol; 2023 Jan; 8(79):eade7953. PubMed ID: 36662884
[TBL] [Abstract][Full Text] [Related]
17. The dynamic functions of IRF4 in B cell malignancies.
Maffei R; Fiorcari S; Atene CG; Martinelli S; Mesini N; Pilato F; Lagreca I; Barozzi P; Riva G; Nasillo V; Paolini A; Forghieri F; Potenza L; Trenti T; Tagliafico E; Luppi M; Marasca R
Clin Exp Med; 2023 Aug; 23(4):1171-1180. PubMed ID: 36495369
[TBL] [Abstract][Full Text] [Related]
18. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
19. Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
Nagata Y; Kontani K; Enami T; Kataoka K; Ishii R; Totoki Y; Kataoka TR; Hirata M; Aoki K; Nakano K; Kitanaka A; Sakata-Yanagimoto M; Egami S; Shiraishi Y; Chiba K; Tanaka H; Shiozawa Y; Yoshizato T; Suzuki H; Kon A; Yoshida K; Sato Y; Sato-Otsubo A; Sanada M; Munakata W; Nakamura H; Hama N; Miyano S; Nureki O; Shibata T; Haga H; Shimoda K; Katada T; Chiba S; Watanabe T; Ogawa S
Blood; 2016 Feb; 127(5):596-604. PubMed ID: 26574607
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
